BSE filing, NSE: VINRKLB. Summary written from the filing by ALFA Finder's alert engine.
Rekvina Laboratories Ltd: key numbers
- Share price
- ₹55.79
- Market cap
- ₹33.63 Cr
- Revenue (annual)
- ₹1.27 Cr
- Net profit (annual)
- ₹-0.25 Cr
- P/E (TTM)
- -99.0×Sector 48.7×
- Promoter holding
- 77.00%+35.70% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rekvina Laboratories Ltd
All →Rekvina Laboratories Business Update
Subsidiary Radiant Parenterals will temporarily shut its manufacturing facility from October 28, 2026. The shutdown supports renovation and installation of an additional vial line.
Rekvina Laboratories Other Announcement
Rekvina Laboratories Limited submitted the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Rekvina Laboratories Management Change
Rekvina Laboratories Limited has appointed Mr. Subrata Samanta as its new Chief Financial Officer and Key Managerial Personnel, effective October 7, 2026.
Rekvina Laboratories Annual General Meeting
Rekvina Laboratories Ltd held its 38th Annual General Meeting on September 29, 2026, approving financial statements and appointing directors.
Rekvina Laboratories Management Change
Rekvina Laboratories Ltd announced a change in its registered office within the city and the resignation of its Managing Director, Mr. Amit Shah.
Rekvina Laboratories Management Change
Mr. Amit Mukesh Shah has resigned as Managing Director and Director of Rekvina Laboratories Limited, effective September 11, 2026.
Other other announcement announcements
All →STL Networks Other Announcement
The Monitoring Agency reported Rs. 2 Crore utilization of Preferential Issue proceeds, with no deviations from objects. The report covers the quarter ending September 30, 2026.
HEG Advanced Materials Other Announcement
HEG Advanced Materials Limited has intimated the exchange regarding the change of its Corporate Identification Number (CIN) following an approved scheme of arrangement.
Sanofi India Other Announcement
Sanofi India issued a communication regarding Tax Deduction at Source (TDS) for the interim dividend declared for FY 2026. Shareholders must update details by November 5, 2026.
Visaka Industries Other Announcement
Visaka Industries informed the exchange about sending reminder letters to shareholders regarding the compulsory transfer of unclaimed dividends and equity shares to the IEPF account.
Arvaya Healthcare Other Announcement
Arvaya Healthcare filed its quarterly shareholding pattern under Regulation 31(1)(c). The filing reports routine ownership breakdowns with no transaction.
AYM Syntex Other Announcement
AYM Syntex's board appointed BSR & Co. LLP as statutory auditor for five years, subject to shareholder approval. Routine auditor appointment; no monetary value involved.
- Execution
- Five consecutive years, from the conclusion of the 44th AGM to the conclusion of the 49th AGM